申请人:Olatec Therapeutics LLC
公开号:US10751316B2
公开(公告)日:2020-08-25
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a methanesulfonylalkylnitrile compound, or a pharmaceutically acceptable salt or solvate thereof. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering a methanesulfonylalkylnitrile compound or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.
本发明涉及一种药物组合物,该组合物包含药学上可接受的载体和甲磺酰基烷基腈化合物或其药学上可接受的盐或溶液。本发明还涉及一种治疗炎症、炎症相关疾病或疼痛的方法,其方法是向有需要的受试者施用甲磺酰基烷基腈化合物或其药学上可接受的盐或溶液。